• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上次心肌梗死与预防性植入式除颤器植入之间的时间间隔对设备检测和治疗的影响。来自 SEARCH MI 登记处的“常规实践”数据。

Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.

机构信息

Institute of Cardiology, University of Bologna, Azienda Ospedaliera S, Orsola-Malpighi; Via Massarenti, 9 40138, Bologna, Italy.

出版信息

BMC Cardiovasc Disord. 2012 Sep 11;12:72. doi: 10.1186/1471-2261-12-72.

DOI:10.1186/1471-2261-12-72
PMID:22966862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3504521/
Abstract

BACKGROUND

A multicenter European Registry, SEARCH-MI, was instituted in the year 2002 in order to assess patients' outcomes and ICD interventions in patients with a previous MI and depressed LV function, treated with an ICD according to MADIT II results. In this analysis, we evaluate the influence of the time elapsed between last myocardial infarction (MI) and prophylactic cardioverter defibrillator (ICD) implant on device activations.

METHODS

643 patients with left ventricular dysfunction (mean LVEF 26 ± 5%) and NYHA class I-III were prospectively followed for 1.8 ± 1.2 years in a multicenter registry. The population was divided into 3 groups according to the time between last MI and ICD implant: [1] from 40 days to less than 1.5 years; [2] from 1.5 to less than 7 years and [3] at least 7 years.

RESULTS

The cumulative incidence of ventricular tachyarrhymias and appropriate device therapy (ATP or shock) were higher in patients implanted longer time from last MI (Gray's Test p=0.002 and p=0.013 respectively). No significant differences were seen in all cause mortality (Gray's Test p=0.618) or sudden cardiac death across the MI stratification groups (Gray's Test p=0.663).

CONCLUSIONS

Patients implanted with an ICD longer after the MI have a higher chance of presenting ventricular tachyarrhythmias and appropriate ICD therapy, while no differences were seen in overall mortality. These observations may be important for improving patient targeting in sudden death prevention.

摘要

背景

为了评估先前患有 MI 和左心室功能降低的患者的结局和 ICD 干预措施,并根据 MADIT II 结果用 ICD 治疗这些患者,于 2002 年建立了一个多中心欧洲注册研究(SEARCH-MI)。在此分析中,我们评估了从上次心肌梗死(MI)到预防性心脏复律除颤器(ICD)植入之间的时间间隔对设备激活的影响。

方法

643 名左心室功能障碍(平均 LVEF 26±5%)和 NYHA Ⅰ-Ⅲ级的患者前瞻性地在多中心注册研究中随访了 1.8±1.2 年。根据上次 MI 和 ICD 植入之间的时间,将人群分为 3 组:[1]从 40 天到小于 1.5 年;[2]从 1.5 年到小于 7 年;[3]至少 7 年。

结果

从上次 MI 到 ICD 植入时间较长的患者发生室性心动过速和适当的设备治疗(ATP 或电击)的累积发生率更高(Gray's Test p=0.002 和 p=0.013)。在 MI 分层组中,全因死亡率(Gray's Test p=0.618)或心源性猝死(Gray's Test p=0.663)均无显著差异。

结论

MI 后植入 ICD 时间较长的患者发生室性心动过速和适当的 ICD 治疗的机会更高,而总死亡率无差异。这些观察结果对于改善预防猝死的患者目标定位可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51e/3504521/8aaefad7b865/1471-2261-12-72-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51e/3504521/f59a8ba55873/1471-2261-12-72-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51e/3504521/8aaefad7b865/1471-2261-12-72-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51e/3504521/f59a8ba55873/1471-2261-12-72-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51e/3504521/8aaefad7b865/1471-2261-12-72-2.jpg

相似文献

1
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.上次心肌梗死与预防性植入式除颤器植入之间的时间间隔对设备检测和治疗的影响。来自 SEARCH MI 登记处的“常规实践”数据。
BMC Cardiovasc Disord. 2012 Sep 11;12:72. doi: 10.1186/1471-2261-12-72.
2
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.适当的植入式心脏复律除颤器治疗在二级预防患者中的死亡率影响:前瞻性基于人群的登记处中一级预防患者死亡率的对比。
J Am Heart Assoc. 2017 Aug 19;6(8):e006220. doi: 10.1161/JAHA.117.006220.
3
Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.慢性肾脏病患者植入式心脏复律除颤器:倾向匹配的死亡率分析
Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1119-27. doi: 10.2215/CJN.11121114. Epub 2015 Jun 25.
4
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.用于心脏性猝死一级预防的植入式心脏复律除颤器发生器更换后的结局
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003283. doi: 10.1161/CIRCEP.115.003283.
5
Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.在 MADIT-II 试验中,从冠状动脉血运重建到植入心脏转复除颤器的时间间隔对长期生存的影响。
J Cardiovasc Electrophysiol. 2011 Nov;22(11):1237-42. doi: 10.1111/j.1540-8167.2011.02096.x. Epub 2011 May 26.
6
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.在心血管研究网络中接受初级预防植入式心脏除颤器的患者中,设备治疗。
J Am Heart Assoc. 2018 Mar 26;7(7):e008292. doi: 10.1161/JAHA.117.008292.
7
Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.心血管磁共振衍生的圆周应变参数与既往心肌梗死和植入式心脏复律除颤器一级预防患者室性心律失常和全因死亡率的相关性研究。
J Cardiovasc Magn Reson. 2019 May 16;21(1):28. doi: 10.1186/s12968-019-0536-5.
8
Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.碎裂 QRS 波在左心室功能障碍的原发性预防植入式心脏复律除颤器患者中的预测价值。
J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):779-84. doi: 10.2459/JCM.0b013e32834ae458.
9
Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).植入式除颤器用于心肌梗死后心肌病患者心脏性猝死一级预防后的临床及心律失常结局:评估高危心肌梗死患者心律失常发生率的研究(SEARCH-MI)
Europace. 2009 Apr;11(4):476-82. doi: 10.1093/europace/eun349. Epub 2009 Jan 9.
10
Heart rate variability density analysis (Dyx) for identification of appropriate implantable cardioverter defibrillator recipients among elderly patients with acute myocardial infarction and left ventricular systolic dysfunction.心率变异性密度分析(Dyx)在急性心肌梗死和左心室收缩功能障碍的老年患者中识别合适的植入式心脏复律除颤器受者的应用。
Europace. 2015 Dec;17(12):1848-54. doi: 10.1093/europace/euu394. Epub 2015 Mar 8.

引用本文的文献

1
Clinical valuation of ST changes in a group of patients with ventricular arrhythmias: The inSighT Study.一组室性心律失常患者ST段改变的临床评估:洞察研究
Ann Noninvasive Electrocardiol. 2022 May;27(3):e12914. doi: 10.1111/anec.12914. Epub 2022 Feb 15.
2
Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.植入式心脏除颤器及再同步治疗在预防心力衰竭心脏性猝死中的作用及应用指征
Heart Fail Rev. 2016 Jul;21(4):433-46. doi: 10.1007/s10741-016-9542-y.

本文引用的文献

1
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).植入式心脏复律除颤器治疗的死亡率获益不仅局限于伴有陈旧性心肌梗死的患者:心力衰竭猝死的心脏停搏试验(SCD-HeFT)的分析结果。
Heart Rhythm. 2011 Mar;8(3):393-400. doi: 10.1016/j.hrthm.2010.11.033. Epub 2010 Nov 23.
2
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.心肌梗死和左心室功能障碍、心力衰竭或两者并存的临床试验中突然意外死亡的发病机制。
Circulation. 2010 Aug 10;122(6):597-602. doi: 10.1161/CIRCULATIONAHA.110.940619. Epub 2010 Jul 26.
3
Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT.MADIT-CRT 研究中冠状动脉血运重建后危及生命的室性心律失常的时间依赖性
Heart Rhythm. 2010 Oct;7(10):1421-7. doi: 10.1016/j.hrthm.2010.07.005. Epub 2010 Jul 8.
4
Role of drugs and devices in patients at risk of sudden cardiac death.药物和器械在有发生心源性猝死风险的患者中的作用。
Fundam Clin Pharmacol. 2010 Oct;24(5):575-94. doi: 10.1111/j.1472-8206.2010.00853.x.
5
Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial.心肌梗死后登记时间与多中心非持续性心动过速试验患者结局的关系。
Europace. 2010 Aug;12(8):1112-8. doi: 10.1093/europace/euq116. Epub 2010 May 7.
6
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.心肌梗死后植入式心脏复律除颤器植入的最佳时机:决策分析。
J Cardiovasc Electrophysiol. 2010 Jul;21(7):791-8. doi: 10.1111/j.1540-8167.2009.01696.x. Epub 2010 Feb 1.
7
The role of cardiac registries in evidence-based medicine.心脏疾病登记系统在循证医学中的作用。
Eur Heart J. 2010 Mar;31(5):525-9. doi: 10.1093/eurheartj/ehp596. Epub 2010 Jan 20.
8
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome.临床试验中植入式心脏电子设备在心力衰竭门诊患者中的应用特征:真实世界的患病率及 1 年预后。
J Eval Clin Pract. 2010 Feb;16(1):82-91. doi: 10.1111/j.1365-2753.2008.01118.x. Epub 2009 Oct 27.
9
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
10
Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).植入式除颤器用于心肌梗死后心肌病患者心脏性猝死一级预防后的临床及心律失常结局:评估高危心肌梗死患者心律失常发生率的研究(SEARCH-MI)
Europace. 2009 Apr;11(4):476-82. doi: 10.1093/europace/eun349. Epub 2009 Jan 9.